Clinical Trial Update: Lantus in the Treatment of Type 1 Diabetes Children [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Lantus (insulin glargine) in children with Type 1 Diabetes has been completed. The study was sponsored by Baylor College of Medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED